The Impact of Fexofenadine Hydrochloride on the Prognosis of Patients Post-Acute Myocardial Infarction
NCT07381803 · Status: RECRUITING · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 2804
Last updated 2026-02-02
Summary
The goal of this study is o evaluate the prognostic effect of fexofenadine hydrochloride in patients with myocardial infarction
Conditions
- Zhejiang University
Interventions
- DRUG
-
Fexofenadine 60 Mg Oral Tablet
Fexofenadine, 60mg BID oral
- DRUG
-
placebo
Sponsors & Collaborators
-
Second Affiliated Hospital, School of Medicine, Zhejiang University
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- TRIPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-01-27
- Primary Completion
- 2026-12-31
- Completion
- 2027-06-30
Countries
- China
Study Locations
More Related Trials
-
Cardioprotective Effect of Dexmedetomidine in Patients With ST-segment Elevation Myocardial Infarction
NCT04912518 ·Status: RECRUITING ·Phase: NA
-
Initial Study of Fenoterol as a Treatment for Heart Failure
NCT01440335 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Assess the Hemodynamic Effects, Safety, Tolerability, and Pharmacokinetics of Intravenous APD418 in Adult Participants With Heart Failure With Reduced Ejection Fraction
NCT05139615 ·Status: TERMINATED ·Phase: PHASE2
-
Impact of a Novel Heart Failure Medication Decision Aid
NCT06247371 ·Status: COMPLETED ·Phase: NA
-
Kinetics of Fluvoxamine and Digoxin in Subjects With Different MDR1 Genotypes
NCT01704638 ·Status: COMPLETED ·Phase: PHASE1
-
Myeloperoxidase (MPO) Inhibitor A_Zeneca for Heart Failure With Preserved Ejection Fraction (HFpEF)
NCT03611153 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Pirfenidone Treat Myocardial Fibrosis After Acute Myocardial Infarction
NCT05531955 ·Status: UNKNOWN ·Phase: PHASE2
-
Efficacy, Safety, and Tolerability of Perhexiline in Subjects With Hypertrophic Cardiomyopathy and Heart Failure
NCT02431221 ·Status: WITHDRAWN ·Phase: PHASE3
-
Bioequivalence Study of Dronedarone Hydrochloride Tablets in Healthy Subjects Under Fasting Conditions
NCT07396506 ·Status: COMPLETED ·Phase: NA
-
Characterization of Changes in Ventricular Mechanics in Response to Lexiscan Stress Using Tagged Cine Cardiac Magnetic Resonance Imaging
NCT02115308 ·Status: COMPLETED ·Phase: PHASE4
-
A Study of the Safety and Efficacy of Follow-up Serial Infusions of Natrecor(Nesiritide) for the Management of Patients With Heart Failure
NCT00091520 ·Status: COMPLETED ·Phase: PHASE2
-
Withdrawal of Pharmacological Treatment in Patients Responding to Cardiac Resynchronization Therapy:
NCT05151861 ·Status: UNKNOWN ·Phase: PHASE4
-
Levosimendan In Ambulatory Heart Failure Patients
NCT04705337 ·Status: TERMINATED ·Phase: PHASE4
-
Dose-comparison Study of Prednisone in Heart Failure
NCT01559727 ·Status: COMPLETED ·Phase: PHASE3
-
An Exploratory Study of 18F-Labeled Hydroxyphenethylguanidines in Heart Failure Patients
NCT02669563 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Safety and Efficacy Study of Once and Twice Daily Doses of MCC-135 in Subjects With Congestive Heart Failure.
NCT00050076 ·Status: COMPLETED ·Phase: PHASE2
-
Regadenoson Combined With Symptom-Limited Exercise in Patients Undergoing Myocardial Perfusion Imaging
NCT01021618 ·Status: COMPLETED ·Phase: NA
-
Preventing Stroke, Premature Death and Cognitive Decline in a Broader Community of Patients With Atrial Fibrillation
NCT04700826 ·Status: RECRUITING ·Phase: PHASE4
-
Feasibility and Effectiveness of Micronutrients as Palliative Care Therapy in Patients With Congestive Heart Failure
NCT01474486 ·Status: COMPLETED ·Phase: NA
-
Study of the Survival of Recombinant Human Neuregulin-1β in Chronic Heart Failure (CHF) Patients
NCT01131637 ·Status: TERMINATED ·Phase: PHASE3
-
Study of Multistep Pharmacological and Invasive Management for Cardiogenic Shock
NCT02591771 ·Status: COMPLETED ·Phase: PHASE2
-
A Phase I/II Clinical Study of SK&F-105517-D in Japanese Patients With Chronic Heart Failure
NCT00742508 ·Status: COMPLETED ·Phase: PHASE1
-
Effects of Intravenous K201 on the Restoration of Sinus Rhythm in Subjects With Symptomatic Atrial Fibrillation
NCT01259622 ·Status: TERMINATED ·Phase: PHASE2
-
SHengXIaN-QuYu DEcoction in Heart Failure With Reduced and Mildly Reduced Ejection Fraction
NCT05583773 ·Status: RECRUITING ·Phase: PHASE4
-
Efficacy and Safety With Early Treatment of Finerenone in Hospitalized Patients With Heart Failure
NCT07397650 ·Status: RECRUITING ·Phase: PHASE4